logo
Europe Bond Sales Are Piling Up in Sign It's Business as Usual

Europe Bond Sales Are Piling Up in Sign It's Business as Usual

Bloomberg6 hours ago

A ceasefire between Israel and Iran — although tentative and possibly fleeting — drew the biggest rush of borrowers in two weeks into Europe's primary bond market.
As many as 19 issuers are looking to raise at least €10.3 billion ($11.9 billion), with the biggest deal a three-part offering from oil and gas giant TotalEnergies SE, according to data compiled by Bloomberg. Many jumped into action having not even publicly announced the sales beforehand.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bitcoin price regains ground as Israel-Iran tensions simmer
Bitcoin price regains ground as Israel-Iran tensions simmer

Yahoo

time33 minutes ago

  • Yahoo

Bitcoin price regains ground as Israel-Iran tensions simmer

Bitcoin (BTC-USD) recovered some of its recent losses on Tuesday, heading 3.5% higher by the afternoon to trade around the $105,427 mark as the world waits for more news on the Iran-Israel ceasefire. The digital commodity, which is typically sensitive to macro events is up 12.8% for the year to date following a slew of crypto-friendly policy decisions by the Trump administration, but had lost around 2.2% over the past month due to a number of other factors. Bitcoin's rally on Tuesday tracked an uptick in global equity markets, after president Donald Trump said in a post on Truth Social that Iran and Israel had agreed a ceasefire. Later on Tuesday, he said both sides had violated the ceasefire. This time last month bitcoin's price against the dollar was at an all-time high of nearly $112,000, but turmoil in the Middle East and uncertainty around US trade and tariff policy has led investors out of riskier assets. "Cryptocurrencies bounced back strongly overnight supported by renewed investor confidence and a shift into higher-risk assets. Bitcoin pushed back above $105,000 having started the week below $100,000," said David Morrison, senior market analyst at FCA regulated fintech and financial services provider Trade Nation. Bitcoin headed higher as the dollar index ( dipped 0.6%. "The US dollar resumed its downward trajectory as safe haven inflows were reversed, the US current account gap widened in Q1 and house prices rose the least in 20 months," said Axel Rudolph, senior technical analyst at online trading platform IG. "The euro was helped by Germany's business climate which hit its highest level in nearly a year with EUR/USD briefly rising to $1.1641, its highest level since October 2021." Other cryptocurrencies also moved higher, with the second largest digital asset, Ethereum, up 6.8% to trade around the $2,440 in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Gene Editing Collaboration, R&D, and Licensing Agreements Analysis Report 2025: Gain Unprecedented Access to Deals Entered Into by the World's Leading Biopharma Companies
Gene Editing Collaboration, R&D, and Licensing Agreements Analysis Report 2025: Gain Unprecedented Access to Deals Entered Into by the World's Leading Biopharma Companies

Associated Press

time34 minutes ago

  • Associated Press

Gene Editing Collaboration, R&D, and Licensing Agreements Analysis Report 2025: Gain Unprecedented Access to Deals Entered Into by the World's Leading Biopharma Companies

DUBLIN--(BUSINESS WIRE)--Jun 24, 2025-- The 'Gene Editing Collaboration and Licensing Deals 2016-2025" has been added to offering. This report contains a comprehensive listing of 384 gene editing deals announced since 2016 including financial terms where available, with links to online deal records of actual gene editing partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents submitted to the Securities Exchange Commission by companies and their partners. Gene Editing Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene editing deals entered into by the world's leading biopharma companies. Fully revised and updated, the report provides details of gene editing deals from 2016 to 2025. The report provides a detailed understanding and analysis of how and why companies enter gene editing deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report includes collaboration, development, research and licensing deals. The initial chapters of this report provide an orientation of gene editing dealmaking. Chapter 1 serves as an introduction to the report. Chapter 2 overviews the trends in gene editing dealmaking since 2016, while Chapter 3 highlights the leading gene editing deals listed by headline value. Chapter 4 details the top 25 most active companies in gene editing dealmaking with a summary and listing of deals, including those with publicly available contract documents. Chapters 5 and 6 provide comprehensive reviews of gene editing deals and partnering deals, respectively, focusing on specific gene editing technology type and available contract documents. The report also includes numerous table and figures that illustrate the trends and activities in gene editing deal making since 2016. In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. Gene Editing Collaboration and Licensing Deals provides the reader with the following key benefits: Analyzing contract agreements allows due diligence of: Key Topics Covered: Executive Summary Chapter 1 - Introduction Chapter 2 - Trends in gene editing dealmaking 2.1. Introduction 2.2. Gene editing deals over the years 2.3. Most active gene editing dealmakers 2.4. Gene editing deals by deal type 2.5. Gene editing deals by therapy area 2.6. Gene editing deals by industry sector 2.7. Deal terms for gene editing deals 2.7.1 Gene editing deals headline values 2.7.2 Gene editing deal upfront payments 2.7.3 Gene editing deal milestone payments 2.7.4 Gene editing royalty rates Chapter 3 - Leading gene editing deals 3.1. Introduction 3.2. Top gene editing deals by value Chapter 4 - Most active gene editing dealmakers 4.1. Introduction 4.2. Most active gene editing dealmakers 4.3. Most active gene editing deals company profiles Chapter 5 - Gene editing contracts dealmaking directory 5.1. Introduction 5.2. Gene editing contracts dealmaking directory Chapter 6 - Gene editing dealmaking by technology type Deal directory Companies Featured (Partial List) For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL GENETICS HEALTH SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 06/24/2025 11:38 AM/DISC: 06/24/2025 11:37 AM

Gold and the Dollar Tumble on Tentative Israel-Iran Ceasefire
Gold and the Dollar Tumble on Tentative Israel-Iran Ceasefire

Yahoo

time35 minutes ago

  • Yahoo

Gold and the Dollar Tumble on Tentative Israel-Iran Ceasefire

The dollar index (DXY00) today is down by -0.41% at a 1-week low. The dollar retreated after President Trump announced a tentative ceasefire between Israel and Iran, which curbed safe-haven demand for the dollar. Also, today's rally in stocks has reduced liquidity demand for the dollar. The dollar weakened further today after an unexpected decline in the Conference Board US June consumer confidence index. Losses in the dollar are contained due to hawkish commentary from Fed Chair Powell and Atlanta Fed President Bostic, who said they are in no hurry to cut interest rates. Palantir, Nuclear Stocks, and the Put/Call Ratio: Key Stocks, Sectors, and Indicators on Watch After U.S. Strikes on Iran Dollar Pressured by Dovish Fed Comments Gold and the Dollar Tumble on Tentative Israel-Iran Ceasefire Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! The US Apr S&P CoreLogic composite-20 home price index rose +3.42% y/y, weaker than expectations of +3.90% y/y and the smallest increase in 1-3/4 years. The Conference Board US Jun consumer confidence index unexpectedly fell -5.4 to 93.0, weaker than expectations of an increase to 99.8. The US June Richmond Fed manufacturing conditions survey unexpectedly rose +2 to -7, stronger than expectations of a decline to -10. Comments from Fed Chair Powell signal he is no rush to cut interest rates when he said, "The effects of tariffs will depend, among other things, on their ultimate level, and for the time being, we are well positioned to wait to learn more about the likely course of the economy before considering any adjustments to our policy stance." Atlanta Fed President Bostic said the Fed doesn't need to cut interest rates, with companies planning to raise prices later this year in response to higher import taxes and with the job market still stable. The markets are discounting the chances at 17% for a -25 bp rate cut after the July 29-30 FOMC meeting. EUR/USD (^EURUSD) today is up by +0.33% and posted a 1-1/2 week high. Today's dollar weakness is benefiting the euro. The euro was also boosted by news that theGerman Jun IFO business climate index rose to a 13-month high. In addition, today's increase in the 10-year German bund yield to a 1-week high strengthened the euro's interest rate differentials. Dovish comments today from ECB Governing Council member Villeroy de Galhau are limiting gains in the euro, as he stated that the ECB can still cut interest rates within the next six months. The German Jun IFO business climate index rose +0.9 to a 13-month high of 88.4, stronger than expectations of 88.0. ECB Governing Council member Villeroy de Galhau said. "If we look at the present assessment of markets so far, inflation expectations remain moderate. If that was confirmed, it could possibly lead in the next six months to further accommodation." Swaps are discounting the chances at 8% for a -25 bp rate cut by the ECB at the July 24 policy meeting. USD/JPY (^USDJPY) today is down by -0.99%. The yen is climbing today on optimism that falling energy costs will boost the Japanese economy after crude prices dropped more than -3% to a 1-1/2 week low. The yen is also finding support today from the dollar's weakness. August gold (GCQ25) today is down -75.10 (-2.21%), and July silver (SIN25) is down -0.837 (-2.31%). Precious metals today are sharply lower, with gold sliding to a 2-week low. An easing of geopolitical risks has sparked a rally in global equity markets and prompted long liquidation pressures in precious metals today on the announcement of a ceasefire in the Israel-Iran conflict. Precious metals added to their losses today on hawkish comments from Fed Chair Powell and Atlanta Fed President Bostic, who signaled the Fed is in no hurry to cut interest rates. On the positive side for precious metals is today's slide in the dollar to a 1-week low. Also, dovish comments today from ECB Governing Council member Villeroy de Galhau were supportive of precious metals when he said the ECB could still cut interest rates further within the next six months. Fund buying of gold continues to support prices as gold holdings in ETFs rose to a 1-3/4 year high Monday. On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store